Nisa Investment Advisors LLC Increases Stake in Thermo Fisher Scientific Inc. (TMO)

Nisa Investment Advisors LLC lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.5% during the fourth quarter, HoldingsChannel reports. The firm owned 158,812 shares of the medical research company’s stock after buying an additional 800 shares during the period. Nisa Investment Advisors LLC’s holdings in Thermo Fisher Scientific were worth $30,155,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. Covington Capital Management raised its stake in shares of Thermo Fisher Scientific by 0.9% during the second quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after buying an additional 20 shares during the last quarter. Investment Centers of America Inc. raised its stake in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after buying an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH raised its stake in shares of Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after buying an additional 23 shares during the last quarter. Bienville Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after buying an additional 27 shares during the last quarter. Finally, Savant Capital LLC raised its stake in shares of Thermo Fisher Scientific by 1.0% during the second quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock worth $487,000 after buying an additional 29 shares during the last quarter. Institutional investors own 86.22% of the company’s stock.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is currently owned by corporate insiders.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $2.37 during trading hours on Friday, reaching $208.66. 1,520,700 shares of the company’s stock traded hands, compared to its average volume of 1,549,575. Thermo Fisher Scientific Inc. has a 1 year low of $140.00 and a 1 year high of $208.72. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. The company has a market capitalization of $83,820.00, a P/E ratio of 35.43, a PEG ratio of 1.65 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 10.44% and a return on equity of 9.09%. The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the firm earned $2.03 earnings per share. The business’s quarterly revenue was up 13.9% on a year-over-year basis. equities analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is presently 10.19%.

TMO has been the subject of a number of recent research reports. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. Leerink Swann boosted their price target on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research note on Monday, October 9th. Goldman Sachs Group initiated coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target for the company. Finally, Evercore ISI initiated coverage on shares of Thermo Fisher Scientific in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $212.21.

TRADEMARK VIOLATION NOTICE: This article was posted by Stock Observer and is the property of of Stock Observer. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thestockobserver.com/2018/01/12/nisa-investment-advisors-llc-increases-stake-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply